AI therapist: could a chatbot ease depression?

NCT ID NCT07500714

Recruiting now Symptom relief Sponsor: National Science and Technology Council, Taiwan Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an AI-driven online cognitive-behavioral therapy (iCBT) for people with major depressive disorder. 100 adults will receive either the AI therapy or a sham relaxation session over 8 weeks. Researchers will track mood, stress, and quality of life to see if the digital approach helps ease symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Internet Cognitive-Behavioral Therapy (iCBT) powered by GPT
What this could lead to: If successful, this could provide a personalized, accessible treatment option for depression that adapts to individual needs.
What could go wrong: This is an early-stage study with only 100 participants, so results may not apply to everyone. The AI-driven therapy is new and may not outperform standard treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSION - MAJOR DEPRESSIVE DISORDER

Contacts and locations

Locations

Mind Body Interface Research Center (MBI Lab & Care)
RECRUITING

Taichung, Taichung, 404, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.